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ABSTRACT
Percutaneus device closure appears to be safe and effective in patients treated for a residual shunt after initial 
surgical closure, as well as after two to three weeks of index myocardial infarction. The index case presented 
with a ventricular septal defect on second of acute myocardial infarction thrombolysed with streptokinase. The 
general condition of the patient was fairly stable. Cardiac catheterization and coronary angiography showed 
significant left to right shunt and there was 90 % proximal stenosis of left anterior descending coronary artery. 
Other coronary arteries were normal. Angioplasty and stenting to the coronary artery lesion was done using 
drug eluting stent (DES) with very good angiographic result. Patient was discharged after four days in stable 
condtion. After 3 weeks his ventricular septal defect was closed percutaneusly using cardio –O-fix device with 
tiny residual shunt. The procedure was uneventful and of brief duration. He was discharged after 5 days of the 
post procedure in very stable condition with minimal residual shunt. A staged procedure is a better option if 
the condition of the patient allows strengthening ventricular septal defect border.
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invasive option, and allows immediate complete closure after 
initial hemodynamic stabilization. Immediate reduction of 
the left-to-right shunt, even if the VSD is not completely 
closed, may stabilize the patient enough to function as a 
bridge to surgery.[6] Current interventional reports are mainly 
restricted to VSD closure in the sub acute or chronic setting, 
or for residual shunts after initial surgical closure.[7-9] We 
report a case of anterior myocardial infarction (MI) which 
was subjected to per-cutaneous transluminal coronary 
angioplasty (PTCA) of the culprit lesion onfourth day of 
myocardial infarction, and closure of VSD with a device 3 
weeks later, to allow reasonable stabilization of patient and 
the rims of the defect.
CASE REPORT
A 60 year old gentleman without previous history of 
hypertension,diabetes mellitus and smoking, sustained 
an acute anterior wall myocardial infarction, and was 
thrombolysed with streptokinase within a window period of 
six hours at a local hospital. He was shifted to our hospital 
Clinical Case Report Based Study
INTRODUCTION
Ventricular septal defect (VSD) complicating acute 
myocardial infarction (AMI) is reported in 0.2 % the patients 
in this thrombolytic era. In the first week, the incidence is 
about 1-2%. On medical management alone, 94 % die within 
30 days.[1,2] Emergent surgical closure of post infarction 
VSD with or without appropriate revascularization 
irrespective of the clinical status had been the standard 
treatment.[3] Mortality rates of surgical closure remain 
high at 20 – 87% in most series.[4,5] Many surgeons prefer 
surgical closure after a 3 – 4 week delay to allow scarring 
of the surrounding tissue, which allows better anchoring of 
sutures. An interventional approach using a device is a less 
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on detection of a ventricular septal defect, ongoing angina 
and breathlessness at rest next day. On admission, he was 
in congestive heart failure of Killip II with a pulse rate of 
109/minute, blood pressure of 100/70 mm Hg and a grade 
IV pan systolic murmur at left lower parasternal area. His 
12 lead surface electrocardiogram (ECG) was consistent with 
evolved acute anterior wall myocardial infarction [Figure 1]. 
Two-dimensional and 3-dimensional echocardiogram 
showed akinetic mid and distal interventricular septum 
and apex, moderate left ventricular dysfunction and a 
muscular ventricular septal defect of 10 mm size in the 
anterior-middle part of the septum [Figure 2]. Cardiac 
catheterization done on the same day revealed a single 
muscular ventricular septal defect of size 10 mm [Figure 3], 
with a significant step up of oxygen saturation at right 
ventricular level by 23% andthe ratio of pulmonary blood 
flow (QP) to the systemic blood flow (Qs) depicted as QP/
QS equal to 1.8:1. Pulmonary artery pressure (40/12/15 
mm Hg) and pulmonary wedge pressure (mean-17 mmHg) 
was mildly elevated. Left Anterior Descending artery was 
the only affected vessel with proximal 90% stenosis (Type B; 
Figure 1: 12 lead electrocardiography shows persistent ST segment 
elevation in V2-V4 even after thrombolysis as an evidence of septal 
aneurysm
Figure 2: Echocardiography in apical four chamber view single and 
discrete muscular septal defect
Figure 3: Left ventricular angiogram in left anterior oblique view shows 
single discrete muscular VSD of size 10mm
Figure 4: Selective coronary hooking of right coronary artery reveals 
normal right coronary artery
Society of Coronary Angiography and Interventions (SCAI) 
[Figures 4 and 5]. Coronary angioplasty using a drug eluting 
(Endeavour Resolute 3 mm × 15 mm) stent was done with 
good angiographic result [Figure 6]. He was pain free and 
asymptomatic since then. The device closure was planned 
after 4 weeks; however had to be done earlier as patient 
was unwilling to stay longer than 3 weeks in hospital due 
to some domestic problem.
Figure 5: Selective left coronary injection shows type B proximal 
significant stenosis in left anterior descending arteryJournal of Cardiovascular Disease Research Vol. 3 / No 2 157
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Figure 6: Successful angioplasty and stenting of left anterior 
descending artery with very good angiographic result
Figure 7: Successful snaring of regular guide wire from left pulmonary 
artery from right internal jugular venous approach
Figure 8: Appropriate placement of Cardio-Fix septal occluder across 
ventricular septal defect with tiny residual shunt is evident from left 
ventricular angiogram in left anterior oblique view
On day-23, the right femoral artery and right internal 
jugular vein were cannulated under local anesthesia. After 
a left ventricular angiogram ventricular septal defect was 
crossed using 5 french right Judkin’s (JR) catheter and a 
0.035” × 260 cm angled tip Terumo wire (Terumo, Tokyo, 
Japan) using a retrograde arterial approach. It was passed 
into right ventricle, to main pulmonary artery and then 
into the left pulmonary artery. The right Judkin’s catheter 
was advanced a little more into Right ventricular outflow 
tract (RVOT) and the Terumo wire was exchanged with 
0.035”× 260 cm Teflon exchange length wire (Medtronic). 
The distal end of that wire was then caught with a 10 mm 
Amplatzer goose-neck snare (Microvena, MN) in the left 
pulmonary artery [Figure 7], and extracted outside via the 
right internal jugular sheath. A 12 Fr 180 degree curve 
device delivery sheath with its dilator (Star Way Medical 
Technology, Inc) was advanced from the jugular vein into 
the left ventricle (LV) across the VSD. Then dilator and 
the guide wire were removed. A 14 mm Cardio-O-Fix 
septal occluder was screwed onto the delivery cable, and 
introduced into the sheath. The distal disc (left ventricle) 
was initially opened and pulled back onto the LV side of 
the septum under trans-thoracic echocardiography (TTE) 
and fluoroscopic guidance. After confirming the septal 
alignment, the proximal disc (right ventricle) was also 
opened. Once adequate placement was ascertained by TTE 
and left ventricular angiogram, the device was released 
[Figure 8]. TTE and left ventricular angiography showed 
proper positioning of device with only minimal shunting 
through the device. Patient remained hemodynamically 
stable after the procedure. The duration of procedure was 
35 minutes. TTE on the next day showed only a trivial 
residual shunt [Figure 9]. The patient was discharged on day 
4 in a stable condition. At 4 month follow-up, he remained 
symptom free and had fair left ventricular function on 
echocardiogram.
DISCUSSION
Ventricular septal defect (VSD) complicates acute 
myocardial infarction in about 1-2% cases in the first 
week.[1] Surgical closure had been the gold standard of 
this fatal complication.[2] As the mortality rates of surgical 
Figure 9: Two dimensional color Doppler showing septal occluder 
exactly across the ventricular septal defect after four days of procedure158  Journal of Cardiovascular Disease Research Vol. 3 / No 2
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closure remains high at 20 – 87% in acute stage, surgeons 
recommend a 3 – 4 week delay to allow scarring of the 
surrounding tissue to occur, which allows for better 
anchoring of sutures. Device closure of post infarction 
VSD is more studied in sub-acute and chronic stages 
and for residual shunts after surgical closure. Till today 
there are no guidelines available for device closure of 
ventricular septal defect after myocardial infarction. The 
small series and anecdotal reports highlighted that device 
closure in acute settings has a high mortality and more 
complications like device embolization, major shunting, 
left ventricular rupture and malignant arrhythmias.[7-10] The 
reported number of interventional post infarction VSD 
procedures till Nov 2009 were less than 200 in literature.[11] 
In a recent study, Demkow and colleagues described their 
5 year experience with Amplatzer device with satisfactory 
results. For very severely ill patients, surgery may be a 
better option.[12-14]
The possible difficulties faced by intervention cardiologist 
are I) lack of expertise due to the rarity of the procedure, 
II) the rigid delivery sheath that has to cross the ventricular 
septal defect (VSD) and needs to be advanced into the 
direction of the left ventricular outflow tract, might tear 
the borders of the VSD, resulting in an increased VSD 
size or, in the worst case, left ventricular rupture III) The 
requirement of guide wire removal after insertion of the 
delivery sheath may result in kinking of sheath or jumping 
of device into right ventricle and IV) The currently available 
device sizes of the muscular VSD occluder not sufficient to 
close the large and complex VSD. Furthermore, healing of 
the infarcted myocardium over time may increase the size 
of the VSD leading to device malposition and embolization. 
This requires the use of devices that are larger than the 
measured VSD size at the time of implantation. The higher 
transventricular pressure for a VSD leads to persistent 
shunting until thrombus formation and endothelialization 
of the device has occurred. In contrast to surgical VSD 
closure, inferior and basal VSDs are more easily closed 
with an interventional technique due to the more favorable 
access from the upper jugular vein.
We critically analyzed all four variables: The hemodynamic 
status, coronary artery disease burden, VSD profile 
and financial aspects before adopting this strategy for 
ventricular defect closure after myocardial infarction. The 
timing of the procedure was critical. As the patient had 
angina and we found a significant critical lesion, we did 
angioplasty of the coronary artery lesion on fourth day. 
As the acute setting has potential for more complications, 
we staged the VSD closure to a later date. We had to take up 
the device closure a few days earlier than a desirable gap of 
4 four weeks as the patient gave only conditional consent. 
Literature review showed only few anecdotal reports for 
device closure with Cardio-O-Fix VSD occluder which is 
used by us. This device is less expensive than commonly 
used ones. The use of this device in a case of post-
operative residual VSD was recently presented in.[15] The 
StarwayCardi-O-Fix VSD Occluder is a self-expandable, 
double disc implant device made from a Nitinol wire mesh. 
The two discs are linked together by a short connecting 
waist corresponding to the size of the VSD. In order to 
increase its closing ability, the discs and the waist are filled 
with polyester fabric. The polyester fabric is securely sewn 
to each disc by surgical sutures. In our experience it is as 
user friendly as Amplatzer VSD occluder.
CONCLUSION
In reasonably hemodynamically stable patient, with a 
favorable coronary anatomy and ventricular septal defect 
anatomy, an initial percutaneous revascularization of 
culprit lesion and elective device closure of VSD at a later 
date may make a safer strategy as alternative to surgery.
This strategy also helps using local anesthesia instead 
of general anesthesia, TTE in place of trans-esophageal 
echocardiogram and Cardio-O-fix device as an used 
alternative to Amplatzer VSD occluder, hence adding to 
the safety and reduced cost of the whole procedure.
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